Human papilloma virus (HPV) vaccination: Questions and answers

Abstract

Get full access to this article

View all access options for this article.

References

Bruni

Diaz

Castellsague

et al . Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202(12):1789-1799.

Moscicki

Palefsky

JM.

HPV in men: an update. J Low Genit Tract Dis 2011;15(3):231-234.

Update on human papillomavirus (HPV) vaccines. Ottawa (ON): Public Health Agency of Canada; 2012. Available: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-1/index-eng.php#a3-3 (accessed Mar. 21, 2016).

Human papilloma virus (HPV) vaccines. British Columbia: HealthLink BC; 2015. Available: http://www.healthlinkbc.ca/healthfiles/hfile101b.stm (accessed Mar. 21, 2016).

Routine immunization schedule. Edmonton (AB): Alberta Health; 2015. Available: http://www.health.alberta.ca/health-info/imm-routine-schedule.html (accessed Mar. 21, 2016).

Human papilloma virus biological page. Edmonton (AB): Alberta Health Services; 2015. Available: http://www.albertahealthservices.ca/assets/info/hp/cdc/if-hp-cdc-hpv-bio-pg-07-240.pdf (accessed Mar. 21, 2016).

Immunization services. Saskatchewan: Government of Saskatchewan; 2014. Available: http://www.saskatchewan.ca/residents/health/accessing-health-care-services/immunization-services#immunization-programs (accessed Mar. 21, 2016).

Routine immunization schedule. Manitoba: Government of Manitoba; 2015. Available: http://www.gov.mb.ca/health/publichealth/cdc/div/schedules.html#child (accessed Mar. 21, 2016).

Manitoba’s immunization program: vaccines offered free of charge (eligibility criteria for publicly-funded vaccines). Manitoba: Government of Manitoba; 2015. Available: http://www.gov.mb.ca/health/publichealth/cdc/vaccineeligibility.html (accessed Mar. 21, 2016).

10.

Ontario’s HPV immunization program. Toronto (ON): Ontario Ministry of Health and Long-Term Care; 2008. Available: http://www.health.gov.on.ca/en/ms/hpv/ (accessed Mar. 21, 2016).

11.

Human papilloma viruses. Quebec: Santé et Services Sociaux Québec; 2016. Available: http://www.msss.gouv.qc.ca/sujets/santepub/vaccination/index.php?aid=193 (accessed Mar. 21, 2016).

12.

Human papillomavirus (HPV) vaccines. Quebec: Portail santé mieux-être; 2016. Available: http://sante.gouv.qc.ca/en/conseils-et-prevention/vaccin-contre-les-infections-par-les-virus-du-papillome-humain-vph/ (accessed Mar. 21, 2016).

13.

Immunization. Newfoundland and Labrador: Department of Health and Community Services; 2016. Available: http://www.health.gov.nl.ca/health/publichealth/cdc/immunizations.html (accessed Mar. 21, 2016).

14.

Routine immunization schedule. New Brunswick: Government of New Brunswick; 2015. Available: http://www2.gnb.ca/content/dam/gnb/Departments/h-s/pdf/en/CDC/Immunization/RoutineImmunizationSchedule.pdf (accessed Mar. 21, 2016).

15.

School immunization schedule. Nova Scotia: Department of Health and Wellness; 2015. Available: http://novascotia.ca/dhw/cdpc/documents/13153_SchoolImmunizationSchedule_En.pdf (accessed Mar. 21, 2016).

16.

Immunization. Prince Edward Island: Department of Health and Wellness; 2016. Available: http://www.gov.pe.ca/health/immunizationschedule (accessed Mar. 21, 2016).

17.

Immunization schedule. Whitehorse: Yukon Health and Social Services; 2015. Available from: http://www.hss.gov.yk.ca/immunizationschedule.php (accessed Mar. 21, 2016).

18.

Northwest Territories (NWT) immunization schedule. Northwest Territories: Northwest Territories Health and Social Services; 2015. Available: http://www.hss.gov.nt.ca/sites/default/files/nwt_immunization_schedule_0.pdf (accessed Mar. 21, 2016).

19.

Public Health Agency of Canada. Canadian immunization guide: human papillomavirus vaccine. Ottawa (ON): Public Health Agency of Canada; 2015.

20.

Markowitz

Dunne

Saraiya

et al . Human papillomavirus vaccination recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014;63(5):1-30.

21.

Kumar

Biswas

Jose

HPV vaccine: current status and future directions. Med J Armed Forces India 2015;71(2):171-177.

22.

Public Health Agency of Canada National Advisory Committee on Immunization. Updated recommendations on human papillomavirus (HPV) vaccines: 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule. Ottawa (ON): Public Health Agency of Canada; 2016.

23.

Schneyer

Yang

Bocchini

JA.

Immunizing adolescents: a selected review of recent literature and US recommendations. Curr Opin Pediatr 2015;27(3):405-417.

24.

Public Health Agency of Canada National Advisory Committee on Immunization. Update on human papillomavirus (HPV) vaccines. CCDR 2012;38:1-62.

25.

Merck Canada Inc. GARDASIL® [Product monograph]. February 2015.

26.

Pan Canadian Cervical Screening Network. Toronto (ON): Canadian Partnership Against Cancer. 2014. Available: http://www.cancerview.ca/cv/portal/Home/PreventionAndScreening/PSProfessionals/PSScreeningAndEarlyDiagnosis/CervicalCancerControlInCanada/PanCanadianCervicalScreeningInitiative?_afrLoop=8375924165715000&lang=en&_afrWindowMode=0&_adf.ctrl-state=1697s2w76l_848 (accessed May 16, 2016).

27.

Merck Canada Inc. GARDASIL®9 [Product monograph]. July 2015.

28.

GlaxoSmithKline Inc. CERVARIX® [Product monograph]. November 2014.

29.

Schiller

Castellsague

Garland

SM.

A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012;30(Suppl 5):F123-F138.

30.

Markowitz

Liu

Hariri

Steinau

Dunne

Unger

ER.

Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 2016;137(3):e20151968.

31.

Castle

Maza

Prophylactic HPV vaccination: past, present and future. Epidemiol Infect 2016;144(3): 449-468.

32.

World Health Organization Strategic Advisory Group of Experts. Evidence based recommendations on human papilloma virus (HPV) vaccines schedules. Geneva: World Health Organization; 2014.

33.

Brotherton

JML

. Human papillomavirus vaccination: where are we now? J Paediatr Child Health 2014;50(12): 959-965.

34.

Tunis

Deeks

, on behalf of the National Advisory Committee on Immunization (NACI). Summary of the National Advisory Committee on immunization’s updated recommendations on human papillomavirus (HPV) vaccines: nine-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule. Can Comm Dis Rep 2016;42:149-151.

35.

Joura

Giuliano

Iverson

et al . A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015;372(8):711-723.

36.

Lexi-Comp. Lexicomp Online. Hudson (OH): Lexi-Comp; 2016.

37.

Human papilloma virus. In: Institute of Medicine, editor. Adverse effects of vaccines: Evidence and causality. Washington, DC: National Academies Press; 2012.

38.

Smith

Kaufman

Strumpf

Levesque

LE.

Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study. CMAJ 2015;187(2):E74-E81.

39.

Feinberg

Pereira

Quach

et al . Understanding public perceptions of the HPV vaccination based on online comments to Canadian news articles. PLoS One 2015;10(6):e012958.

40.

Brisson

Laprise

Drolet

et al . Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study. Vaccine 2014;32(44):5845-5853.

41.

Nielsen

Hayney

MS.

Human papillomavirus: a brief overview and recommendations for pharmacists. J Am Pharm Assoc 2014;54(5):558-561.

42.

Krawczyk

Knauper

Gilca

et al . Parents’ decision-making about the human papillomavirus vaccine for their daughters: i. quantitative results. Hum Vaccin Immunother 2015;11(2):322-329.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB